<div id="readability-page-1"><div><p>Sept 25 (Reuters) - Vertex Pharmaceuticals Inc:</p><ul><li>Vertex announces key advancements across kidney portfolio</li><li>   Vertex Pharmaceuticals Inc: FDA granted breakthrough therapy designation for povetacicept in IgA nephropathy</li><li>   Vertex Pharmaceuticals Inc - on track to file for accelerated approval in U.S. in H1 2026</li></ul></div></div>

福泰制药

<p>9 月 25 日（路透社）- Vertex Pharmaceuticals Inc：Vertex 宣布肾脏产品组合的关键进展 Vertex Pharmaceuticals Inc：FDA 授予 povetacicept 在 IgA 肾病中的突破性疗法认定 Vertex Pharmaceuticals Inc - 预计将在 2026 年上半年申请美国的加速批准</p>

福泰制药宣布其在肾脏产品组合方面取得关键进展